USPTO serial 78736498
AMGEN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 10, 2007
- Examiner
- FAIRBANKS, RONALD L
- Law office
- GENERIC WEB UPDATE
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with AMGEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,544*
Plus Government fees of $3,900
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Thousand Oaks, CA, US
Thousand Oaks, CA, US
Thousand Oaks, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Elsa D. Lemoine
Elsa D. Lemoine Amgen Inc.One Amgen Center DriveTrademark Operations - MS-28-5AThousand Oaks, CA 91320-1799Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | House mark for a full line of pharmaceuticals; and pharmaceuticals, including human recombinant erythropoietin and erythropoiesis stimulating protein; pharmaceuticals for use in stimulating production of red blood cells, white blood cells or platelets; pharmaceuticals for modulating calcium, phosphorus, or parathyroid hormone levels in the blood or for treatment of hyperparathyroidism, hypercalcemia or bone metabolism related disorders and diseases; pharmaceuticals for treating human immune diseases and conditions; pharmaceuticals for the treatment of viral infections, neoplastic, metabolic, autoimmune or inflammatory disorders; [ pharmaceuticals for the treatment of injury to epithelial cells and tissues; pharmaceuticals for modulating weight loss, regulating reproductive function and promoting wound healing, and for use in the treatment of obesity, diabetes, hypertension, dyslipidemia and cardiovascular diseases and infertility; and support kits for patients afflicted with autoimmune or inflammatory disorders, comprised primarily of materials for wound dressing and sterilization and a device for delivery of a drug; ] one or more of the aforementioned pharmaceutical preparations sold in prefilled syringes | ACTIVE | — |
| 010 | [ a reusable device which assists in removing needle guards and adds stability to delivery of drugs by syringe and a reusable spring-loaded medical syringe holder for facilitating delivery of drugs by syringe ] | SECTION 8 - CANCELLED | Nov 20, 2001 |
| 035 | [ billing services and ] referral services in the field of treatment for cancer, chemotherapy and pharmaceutical products | ACTIVE | Oct 4, 2001 |
| 036 | administration of patient reimbursement programs | ACTIVE | Oct 4, 2001 |
| 041 | educational services, namely development and dissemination of educational materials of others in the fields of pharmaceutical products and treatment of medical disorders; conducting seminars regarding the use of prescription pharmaceutical products for medical disorders; providing a motivational and educational speaker featuring information regarding medical disorders | ACTIVE | Oct 6, 1997 |
| 042 | medical research namely, clinical trial services | ACTIVE | Jan 1, 1981 |
| 044 | patient support services relating to the treatment of medical disorders, namely, providing online information regarding pharmaceutical preparations for treatment of various diseases; providing health and medical information about medical disorders; information services, namely, providing medical information to cancer patients; information services relating to medical services via a global computer network, namely, providing medical consultancy and advisory services via a global computer network | ACTIVE | Mar 31, 2002 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Amgen Inc.
- Other trademarks owned by Amgen Inc.
- Other trademarks owned by Amgen Inc.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named AMGEN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 10, 2026 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Feb 25, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 25, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 25, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 25, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 25, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 29, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 29, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 29, 2022 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Apr 29, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 29, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 29, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 7, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 7, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 2, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 2, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 28, 2017 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Mar 28, 2017 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Mar 28, 2017 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Mar 27, 2017 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Apr 10, 2016 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Apr 5, 2013 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Apr 5, 2013 | C15P | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Apr 5, 2013 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 25, 2013 | 815F | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | — |
| Mar 25, 2013 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Apr 10, 2007 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 23, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 3, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Dec 5, 2006 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 5, 2006 | ALIE | ASSIGNED TO LIE | — |
| Nov 16, 2006 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 1, 2006 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 31, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 31, 2006 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 26, 2006 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 26, 2006 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 1, 2006 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 1, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 23, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 25, 2005 | NWAP | NEW APPLICATION ENTERED | — |